Ryan Rodriguez

Amgen (United States) — United States

Medicine · Health Sciences

6h-index366citations65works1.92yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cancer Immunotherapy and Biomarkers(38), Immune cells in cancer(20), interferon and immune responses(20), CAR-T cell therapy research(17), Viral Infections and Vectors(15)

Publications65 total

Supplementary Figure 2 from The Exonuclease TREX1 Constitutes an Innate Immune Checkpoint Limiting cGAS/STING-Mediated Antitumor Immunity
2024Open Access
Supplementary Figure 6 from The Exonuclease TREX1 Constitutes an Innate Immune Checkpoint Limiting cGAS/STING-Mediated Antitumor Immunity
2024Open Access
Supplementary Figure 3 from The Exonuclease TREX1 Constitutes an Innate Immune Checkpoint Limiting cGAS/STING-Mediated Antitumor Immunity
2024Open Access
Supplementary Figure 2 from The Exonuclease TREX1 Constitutes an Innate Immune Checkpoint Limiting cGAS/STING-Mediated Antitumor Immunity
2024Open Access
Data from The Exonuclease TREX1 Constitutes an Innate Immune Checkpoint Limiting cGAS/STING-Mediated Antitumor Immunity
2024· 1 citedOpen Access
Supplementary Figure 3 from The Exonuclease TREX1 Constitutes an Innate Immune Checkpoint Limiting cGAS/STING-Mediated Antitumor Immunity
2024Open Access
Supplementary Figure 4 from The Exonuclease TREX1 Constitutes an Innate Immune Checkpoint Limiting cGAS/STING-Mediated Antitumor Immunity
2024Open Access
Supplementary Table 2 from The Exonuclease TREX1 Constitutes an Innate Immune Checkpoint Limiting cGAS/STING-Mediated Antitumor Immunity
2024Open Access
Supplementary Figure 1 from The Exonuclease TREX1 Constitutes an Innate Immune Checkpoint Limiting cGAS/STING-Mediated Antitumor Immunity
2024Open Access
Data from The Exonuclease TREX1 Constitutes an Innate Immune Checkpoint Limiting cGAS/STING-Mediated Antitumor Immunity
2024Open Access
Supplementary Table 1 from The Exonuclease TREX1 Constitutes an Innate Immune Checkpoint Limiting cGAS/STING-Mediated Antitumor Immunity
2024Open Access
Supplementary Table 1 from The Exonuclease TREX1 Constitutes an Innate Immune Checkpoint Limiting cGAS/STING-Mediated Antitumor Immunity
2024Open Access
Supplementary Figure 1 from The Exonuclease TREX1 Constitutes an Innate Immune Checkpoint Limiting cGAS/STING-Mediated Antitumor Immunity
2024Open Access
Supplementary Figure 5 from The Exonuclease TREX1 Constitutes an Innate Immune Checkpoint Limiting cGAS/STING-Mediated Antitumor Immunity
2024Open Access
Supplementary Figure 4 from The Exonuclease TREX1 Constitutes an Innate Immune Checkpoint Limiting cGAS/STING-Mediated Antitumor Immunity
2024Open Access
Supplementary Figure 6 from The Exonuclease TREX1 Constitutes an Innate Immune Checkpoint Limiting cGAS/STING-Mediated Antitumor Immunity
2024Open Access
Supplementary Table 2 from The Exonuclease TREX1 Constitutes an Innate Immune Checkpoint Limiting cGAS/STING-Mediated Antitumor Immunity
2024Open Access
Supplementary Figure 5 from The Exonuclease TREX1 Constitutes an Innate Immune Checkpoint Limiting cGAS/STING-Mediated Antitumor Immunity
2024Open Access
Abstract LB361: The exonuclease TREX1 constitutes an innate immune checkpoint limiting cGAS/STING-mediated anti-tumor immunity
Cancer Research·2024
The Exonuclease TREX1 Constitutes an Innate Immune Checkpoint Limiting cGAS/STING-Mediated Antitumor Immunity
Cancer Immunology Research·2024· 38 citedOpen Access
page 1 of 4Next →

Frequent Co-authors

Huizhong Xiong(30), Марина Москаленко(30), Stephanie Mittman(29), Rafael Cubas(29), Yagai Yang(28), Sören Müller(28), Lélia Delamarre(28), Ira Mellman(28), Patricia Pacheco-Sanchez(27), Dorothee Nickles(27), J. K. Lim(15), Katherine Williams(15), John Silva(15), Paul Tyler(15), Faezzah Baharom(15), Tao Sun(15), Eva Lin(15), Scott E. Martin(15), Brandon D. Kayser(15), Robert J. Johnston(15)